Avadel Pharmaceuticals

Avadel Pharmaceuticals products

LUMRYZ (sodium oxybate extended-release oral suspension)
Indication: Once-nightly treatment for excessive daytime sleepiness (EDS) and cataplexy in narcolepsy
Status: Approved in the U.S. for adults and children aged 7 years and older

FT218 (sodium oxybate—Micropump® formulation)
Indication: Once-nightly extended-release sodium oxybate for idiopathic hypersomnia
Status: Phase III clinical development